YARROW BIOSCIENCE, INC. Other Noncash Income (Expense)
YARROW BIOSCIENCE, INC. (YARW) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2023-03-14
- YARROW BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2022-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2022-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for fiscal 2022 was $0.00.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for fiscal 2021 was -$2.47M, a 477.98% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for fiscal 2020 was $654.00K.
- YARROW BIOSCIENCE, INC. other noncash income (expense) for fiscal 2019 was -$140.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $0.00 10-K · filed 2023-03-14 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | -$1.19M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | -$1.19M derived: sum of 3 quarters · filed 2023-03-14 | -$2.62M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | -$1.19M derived: sum of 2 quarters · filed 2023-03-14 | -$2.62M derived: sum of 3 quarters · filed 2023-03-14 | -$2.54M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$2.62M derived: sum of 2 quarters · filed 2023-03-14 | -$2.54M derived: sum of 3 quarters · filed 2023-03-14 | -$2.47M 10-K · filed 2023-03-14 | |
| 2021-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.35M derived: sum of 2 quarters · filed 2022-11-14 | -$1.28M 10-Q · filed 2022-11-14 | -$1.35M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $150.00K 10-Q · filed 2022-08-12 | $77.00K derived: sum of 3 quarters · filed 2022-08-12 | -$29.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $66.00K 10-Q · filed 2022-05-12 | -$7.00K derived: sum of 2 quarters · filed 2022-05-12 | -$113.00K derived: sum of 3 quarters · filed 2022-05-12 | $373.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$179.00K derived: sum of 2 quarters · filed 2022-03-17 | $307.00K derived: sum of 3 quarters · filed 2022-03-17 | $654.00K 10-K · filed 2022-03-17 | $542.00K 10-K · filed 2021-03-04 |
| 2020-09-30 | -$106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $380.00K derived: sum of 2 quarters · filed 2021-11-10 | $727.00K 10-Q · filed 2021-11-10 | $672.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $486.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $833.00K 10-Q · filed 2021-08-12 | $778.00K derived: sum of 3 quarters · filed 2021-08-12 | $696.00K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $347.00K 10-Q · filed 2021-05-06 | $292.00K derived: sum of 2 quarters · filed 2021-05-06 | $210.00K derived: sum of 3 quarters · filed 2021-05-06 | $230.00K derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$137.00K derived: sum of 2 quarters · filed 2021-03-04 | -$117.00K derived: sum of 3 quarters · filed 2021-03-04 | -$140.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$62.00K derived: sum of 2 quarters · filed 2020-11-05 | -$85.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$3.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$23.00K 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | -$43.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |